Varian Medical Systems, Inc. Management to Present At UBS Warburg Global Life Sciences Conference | Varian

Varian Medical Systems, Inc. Management to Present At UBS Warburg Global Life Sciences Conference

PALO ALTO, Calif., Oct 5, 2001 (BW HealthWire) -- Varian Medical Systems (NYSE:VAR) President and CEO Richard M. Levy and Chief Financial Officer Elisha W. Finney are scheduled to make a presentation at the UBS Warburg Global Life Sciences Conference in New York at 8 a.m. EDT this Wednesday, Oct. 10. The presentation will include a company profile, market position and drivers, an overview of products and treatment technologies including SmartBeam(R) IMRT, and a review of past financial performance.

The public can hear the Varian Medical Systems' presentation at the UBS Warburg conference via telephone by calling 800/500-0177 (domestic) and +1 719 457-2679 (international) at 8 a.m. EDT on Wednesday. Replays of the presentation will be available for the following four weeks by calling 800/759-8603 (domestic) or +1 402 220-8537 (international). Presentation materials will be available on the investor relations page of the company website at www.varian.com.

Varian Medical Systems, Inc., (NYSE:VAR) of Palo Alto, is the world's leading manufacturer of integrated cancer therapy systems, which are treating thousands of patients per day. The company is also a premier supplier of X-ray tubes and flat-panel digital subsystems for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 2,500 people who are located at manufacturing sites in North America and Europe and in its 40 sales and support offices around the world. In its fiscal year ended Sept. 29, 2000, Varian Medical Systems reported sales of $690 million. Additional information is available on the company's investor relations web site at www.varian.com.

CONTACT:
Varian Medical Systems, Inc.
Elisha Finney, 650/424-6803
Spencer Sias, 650/424-5782